Christopher H. Wade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christopher H. Wade has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Theresa Mary Marteau
Behaviour and Health Research Unit University of Cambridge UK
2 shared publications B.B. Biesecker
Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Md., USA
1 shared publicationBarbara B. Biesecker
Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health
1 shared publication- Benjamin S. Wilfond
B Seattle Children's Research Institute
1 shared publication - Beth Anne Tarini
Children's National Health System Washington District of Columbia USA
1 shared publication J. Scott Roberts
University of Michigan School of Public Health
1 shared publication
Latest Publications
- 31 August 2013
- Published by Annual Reviews in Annual Review of Genomics and Human Genetics
- Vol. 14 (1) , 535-555
Growing Up in the Genomic Era: Implications of Whole-Genome Sequencing for Children, Families, and Pediatric Practice
Whole-genome sequencing (WGS) has advanced to a point where it is beginning to be integrated into pediatric practice. With little consensus on how to maximize the benefits of WGS for children, there is a growing need for focused efforts that connect researchers, clinicians, and families to chart a path forward. To illustrate relevant concerns, two contrasting applications of pediatric WGS are explored: clinical use with children who have undiagnosed conditions, and population-based screening. Specific challenges for health care services, policy development, and the well-being of children are discussed in light of current research. In the interest of ensuring evidence-based pediatric WGS, strategies are identified for advancing our understanding of what it means for children to grow up with WGS results guiding their health care.
- 31 August 2013
- Published by Annual Reviews in Annual Review of Genomics and Human Genetics
- Vol. 14 (1) , 535-555
Growing Up in the Genomic Era: Implications of Whole-Genome Sequencing for Children, Families, and Pediatric Practice
Whole-genome sequencing (WGS) has advanced to a point where it is beginning to be integrated into pediatric practice. With little consensus on how to maximize the benefits of WGS for children, there is a growing need for focused efforts that connect researchers, clinicians, and families to chart a path forward. To illustrate relevant concerns, two contrasting applications of pediatric WGS are explored: clinical use with children who have undiagnosed conditions, and population-based screening. Specific challenges for health care services, policy development, and the well-being of children are discussed in light of current research. In the interest of ensuring evidence-based pediatric WGS, strategies are identified for advancing our understanding of what it means for children to grow up with WGS results guiding their health care.
- Open Access
- 8 June 2012
- Published by S. Karger AG in Public Health Genomics
- Vol. 15 (6) , 322-326
Preferences among Diseases on a Genetic Susceptibility Test for Common Health Conditions: An Ancillary Study of the Multiplex Initiative
The potential integration of whole genome sequencing into standard healthcare practice presents an array of challenges for clinicians [1]. Among these are concerns about whether clinicians with limited time are prepared to effectively communicate about complex multi-disease genetic risk results and what key information patients need to comprehend [2,3,4]. In narrowing down the essential topics to be discussed with patients, it will be necessary to determine whether genomic testing should be treated as a single entity (i.e. patients would decide whether to have the test and receive all or none of the genetic risk information) or provision of each health condition on the test should be explored independently (i.e. patients would make disease-specific decisions).
- 8 June 2012
- Published by S. Karger AG in Public Health Genomics
- Vol. 15 (6) , 322-326
Open AccessPreferences among Diseases on a Genetic Susceptibility Test for Common Health Conditions: An Ancillary Study of the Multiplex Initiative
The potential integration of whole genome sequencing into standard healthcare practice presents an array of challenges for clinicians [1]. Among these are concerns about whether clinicians with limited time are prepared to effectively communicate about complex multi-disease genetic risk results and what key information patients need to comprehend [2,3,4]. In narrowing down the essential topics to be discussed with patients, it will be necessary to determine whether genomic testing should be treated as a single entity (i.e. patients would decide whether to have the test and receive all or none of the genetic risk information) or provision of each health condition on the test should be explored independently (i.e. patients would make disease-specific decisions).
- 8 June 2011
- Published by Taylor & Francis in Psychology & Health
- Vol. 27 (4) , 430-444
Modelling decisions to undergo genetic testing for susceptibility to common health conditions: An ancillary study of the Multiplex Initiative
New genetic tests reveal risks for multiple conditions simultaneously, although little is understood about the psychological factors that affect testing uptake. We assessed a conceptual model called the multiplex genetic testing model (MGTM) using structural equation modelling. The MGTM delineates worry, perceived severity, perceived risk, response efficacy and attitudes towards testing as predictors of intentions and behaviour. Participants were 270 healthy insured adults aged 25–40 from the Multiplex Initiative conducted within a health care system in Detroit, MI, USA. Participants were offered a genetic test that assessed risk for eight common health conditions. Confirmatory factor analysis revealed that worry, perceived risk and severity clustered into two disease domains: cancer or metabolic conditions. Only perceived severity of metabolic conditions was correlated with general response efficacy (β = 0.13, pβ = 0.24, pβ = 0.49, pβ = 0.97, p<0.01). The MGTM explained a striking 48% of the variance in intentions and 94% of the variation in uptake. These findings support use of the MGTM to explain psychological predictors of testing for multiple health conditions.
- 8 June 2011
- Published by Taylor & Francis in Psychology & Health
- Vol. 27 (4) , 430-444
Modelling decisions to undergo genetic testing for susceptibility to common health conditions: An ancillary study of the Multiplex Initiative
New genetic tests reveal risks for multiple conditions simultaneously, although little is understood about the psychological factors that affect testing uptake. We assessed a conceptual model called the multiplex genetic testing model (MGTM) using structural equation modelling. The MGTM delineates worry, perceived severity, perceived risk, response efficacy and attitudes towards testing as predictors of intentions and behaviour. Participants were 270 healthy insured adults aged 25–40 from the Multiplex Initiative conducted within a health care system in Detroit, MI, USA. Participants were offered a genetic test that assessed risk for eight common health conditions. Confirmatory factor analysis revealed that worry, perceived risk and severity clustered into two disease domains: cancer or metabolic conditions. Only perceived severity of metabolic conditions was correlated with general response efficacy (β = 0.13, pβ = 0.24, pβ = 0.49, pβ = 0.97, p<0.01). The MGTM explained a striking 48% of the variance in intentions and 94% of the variation in uptake. These findings support use of the MGTM to explain psychological predictors of testing for multiple health conditions.